JBT Marel Corporation

NYSE:JBTM Lagerbericht

Marktkapitalisierung: US$6.9b

JBT Marel Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Für JBT Marel wird ein Gewinn- und Umsatzwachstum von 39.1% bzw. 4.9% pro Jahr prognostiziert, während der Gewinn je Aktie voraussichtlich um 38.5% pro Jahr steigen soll.

Wichtige Informationen

39.1%

Wachstumsrate der Gewinne

38.49%

EPS-Wachstumsrate

Machinery Gewinnwachstum16.5%
Wachstumsrate der Einnahmen4.9%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Good

Zuletzt aktualisiert21 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrativ-Update • May 18

JBTM: 2026 Sector Assumptions And Execution Will Shape Balanced Return Potential

Analysts have raised JBT Marel's price targets to $190 and $202 in recent updates, citing expected sector trends in 2026, changes in valuation, and refreshed models following the Q4 results as key reasons for the higher targets. Analyst Commentary Recent research updates on JBT Marel highlight higher price targets of $190 and $202, tied to refreshed models after Q4 results, sector expectations for 2026, and reassessments of valuation.
Analyseartikel • May 14

Solid Earnings Reflect JBT Marel's (NYSE:JBTM) Strength As A Business

When companies post strong earnings, the stock generally performs well, just like JBT Marel Corporation's ( NYSE:JBTM...
Narrativ-Update • May 02

JBTM: 2026 Sector Tailwinds And Capital Plans Will Support Upside

Narrative Update: JBT Marel Analysts have lifted JBT Marel's implied upside, with recent price targets rising toward the $190 to $202 range. They point to updated models, modest tweaks to growth and margin assumptions, and supportive 2026 sector trends.
Seeking Alpha • Apr 26

JBT Marel's Growth Plans Justify An Upgrade

Summary JBT Marel Corporation is upgraded from 'hold' to a soft 'buy' based on ambitious growth and cost-saving targets. JBTM expects organic revenue growth of 5–7% annually through 2028, targeting $4.52 billion in sales and 20% EBITDA margins. Management projects $150 million in annual cost savings by the end of next year, with additional revenue and operational synergies supporting margin expansion. Forward valuation multiples suggest 63–69% upside by 2028, offering potential annualized returns of 17.8–19.2% versus the S&P 500. Read the full article on Seeking Alpha
Narrativ-Update • Apr 18

JBTM: 2026 Sector Tailwinds And Capital Plans Are Expected To Support Upside

Analysts have raised JBT Marel's price target to a range of about $190 to $202, up from prior views around $165 to $169. They cite updated models after Q4 results, supportive 2026 sector trends, and evidence of a valuation gap.
Narrativ-Update • Apr 03

JBTM: Higher 2026 Sector Trends And Capital Plans May Support Upside

Analysts have raised their fair value estimate for JBT Marel from $177.50 to $210.00, citing higher price targets from recent Q4 model updates and 2026 sector trend work, which they view as supportive for the stock. Analyst Commentary Recent Street research has turned more constructive on JBT Marel, with higher price targets tied directly to updated models and sector work.
Narrativ-Update • Mar 20

JBTM: 2026 Sector Setup And Food Tech Hub Will Shape Upside Outlook

Analysts have lifted their JBT Marel price target from $160.25 to about $182, citing updated models after recent Q4 results, positive 2026 sector trends, and a reassessment of the valuation gap relative to peers. Analyst Commentary Bullish Takeaways Bullish analysts see the move in price targets toward the US$190 to US$202 range as a reset that better reflects their updated models after Q4, rather than a stretch valuation.
Narrativ-Update • Mar 06

JBTM: Long Dated 2026 Assumptions Will Pressure Future Share Returns

Analysts have lifted their JBT Marel price target range from about $165 to around $202, citing updated models after Q4 results, positive 2026 sector trends, and a reassessment of valuation that now supports a fair value estimate of roughly $121, a lower discount rate of 8.85%, and a higher future P/E assumption of about 18.7, despite more conservative revenue growth and profit margin inputs. Analyst Commentary The latest research updates on JBT Marel center on refreshed models after Q4 results and a reassessment of what investors may be willing to pay for the stock, with reference targets in a range around $190 to $202 and an implied fair value closer to $121.
Narrativ-Update • Feb 19

JBTM: Lower Future P E Multiple Will Weigh On Share Returns

Analysts have maintained their price target for JBT Marel at $105.41, highlighting slightly revised assumptions for the discount rate, revenue growth, profit margin, and future P/E as the main factors supporting this unchanged outlook. What's in the News JBT Marel held an Investor Day event, giving analysts and investors a closer look at the business, capital allocation priorities, and long term financial framework (Key Developments).
Narrativ-Update • Feb 05

JBTM: Projected Margins And P E Reset Will Pressure Share Price

Analysts have maintained their price target for JBT Marel at $105.41. They cite updated assumptions for the discount rate, revenue growth, profit margins and future P/E that keep their valuation view essentially unchanged.
Narrativ-Update • Jan 22

JBTM: Expected 2025 Losses Will Likely Undermine Current Share Price

Analysts have adjusted their price target for JBT Marel to US$105.41, reflecting updated views on discount rates, revenue growth, profit margins, and future P/E assumptions. What's in the News JBT Marel plans an Investor Day event, providing management an opportunity to update investors on the business and capital allocation plans (Key Developments).
Narrativ-Update • Jan 08

JBTM: Investor Day And New Food Solutions Will Shape Balanced Future Outlook

Narrative Update on JBT Marel Analysts have lifted their price target on JBT Marel by US$5 to US$160.25, reflecting updated assumptions for slightly higher revenue growth and a higher future P/E multiple, alongside modest adjustments to the discount rate and profit margin outlook. What's in the News JBT Marel plans to host an Investor Day, giving management a platform to update investors on the business, capital allocation, and medium term priorities (Key Developments).
Analyseartikel • Dec 31

We Think JBT Marel (NYSE:JBTM) Is Taking Some Risk With Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Narrativ-Update • Dec 23

JBTM: Higher Profit Margins Will Likely Fail To Justify Current Price

Analysts have raised their price target on JBT Marel from approximately 88 dollars to 105 dollars, citing expectations for stronger long term profitability despite moderating revenue growth and a lower projected valuation multiple. What's in the News Raised 2025 revenue guidance to a range of 3,760 million dollars to 3,790 million dollars, signaling confidence in underlying demand despite moderating growth expectations (Corporate Guidance) Updated 2025 GAAP loss per share outlook to a narrower range of 1.05 dollars to 0.75 dollars, highlighting anticipated margin improvements and cost discipline (Corporate Guidance) Launched the Fresh'n Squeeze 1800 Citrus Juicer, a compact countertop system using the company’s industrial grade whole fruit extraction technology to boost juice yield by up to 50 percent per fruit versus traditional cut and press methods (Product Announcement) Positioned the Fresh'n Squeeze 1800 as a labor saving, space efficient solution for grocery retailers, juice bars, hotels, resorts, and coffee shops, enabling menu diversification and new revenue streams from fresh citrus offerings (Product Announcement) Valuation Changes The fair value estimate has risen significantly from approximately 88.23 dollars to 105.41 dollars per share, reflecting higher expected long term profitability.
Narrativ-Update • Dec 09

JBTM: New Food-Processing Offerings Will Drive Margin Expansion And Future Upside

Analysts have modestly raised their price target on JBT Marel, now implying fair value of approximately $155.25 per share. They cite slightly higher long term discount rate assumptions while maintaining robust revenue growth, profit margin, and future valuation expectations.
Narrativ-Update • Nov 25

JBTM: Margin Expansion And New Offerings Will Drive Future Upside

Analysts have raised their price target for JBT Marel to $155.25 from $152.75, citing modest improvements in profit margin projections as the primary driver for this upward adjustment. What's in the News JBT Marel has raised its earnings guidance for the full year 2025, projecting revenue between $3,760 million and $3,790 million and GAAP LPS in the range of $1.05 to $0.75 (Company Guidance).
Narrativ-Update • Nov 07

JBTM: Future Expansion Will Stem From Margin Gains Amid Slower Revenue Growth

Analysts have raised their price target for JBT Marel from $149.42 to $152.75, citing improved profit margin expectations, even as projected revenue growth is expected to moderate. What's in the News JBT Marel raised its earnings guidance for the full year 2025, forecasting revenue between $3,760 million and $3,790 million and GAAP loss per share in the range of $1.05 to $0.75 (Key Developments).
Narrativ-Update • Sep 20

Global Protein Demand And Automation Will Drive Future Expansion

The downward revision of JBT Marel's consensus analyst price target primarily reflects a decline in the anticipated future P/E ratio, with fair value lowered from $162.30 to $149.42. What's in the News JBT Marel is showcasing several innovations at Pack Expo Las Vegas, including the launch of the CIPure Cleaning System, new juicing and pet food technologies, tray sealers, slicers, and a 3D model of a fresh salad line, alongside immersive VR experiences.
Narrativ-Update • Sep 05

Global Protein Demand And Automation Will Drive Future Expansion

The increase in JBT Marel’s consensus analyst price target to $162.30 is primarily driven by a higher forecast valuation multiple (Future P/E), with revenue growth expectations remaining steady. What's in the News JBT Marel re-established full year 2025 earnings guidance, projecting revenue of $3,675 million to $3,725 million, a loss from continuing operations margin of 2.7% to 1.7%, and GAAP loss per share of $1.90 to $1.20.
Narrativ-Update • Aug 07

Global Protein Demand And Automation Will Drive Future Expansion

Despite a notable decline in consensus revenue growth forecasts, JBT Marel's consensus analyst price target has been significantly raised, driven by higher anticipated future P/E multiples, with the fair value increasing from $129.40 to $149.42. What's in the News JBT Marel re-established 2025 revenue guidance of $3,675 million to $3,725 million, with an expected GAAP loss per share of $1.90 to $1.20 and a loss margin of 2.7% to 1.7%, aided by a $70 million to $85 million foreign exchange tailwind.
User avatar
Neues Narrativ • Feb 09

Merger With Marel Will Improve Operational Efficiency And Create Synergies

Strong revenue growth and margin expansion driven by recovery in key markets and beneficial restructuring efforts could boost future earnings.
User avatar
Neues Narrativ • Sep 09

JBT's Calculated Mergers And Efficiency Gains Promise Robust Revenue And Margin Growth

Strategic expansion and diversification through the proposed merger with Marel promises to enhance market position and drive revenue growth.

Gewinn- und Umsatzwachstumsprognosen

NYSE:JBTM - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20274,2253444685856
12/31/20264,0282554625546
3/31/20263,880168317427N/A
12/31/20253,798-50238342N/A
9/30/20253,258-110273353N/A
6/30/20252,710-138283338N/A
3/31/20252,178-111210257N/A
12/31/20241,71685196234N/A
9/30/20241,6931444077N/A
6/30/20241,643137-1724N/A
3/31/20241,668135-1832N/A
12/31/20231,664129-1540N/A
9/30/20231,66110968136N/A
6/30/20231,65610469146N/A
3/31/20231,62310146120N/A
12/31/20221,59010456141N/A
9/30/20221,64710352135N/A
6/30/20221,72510762139N/A
3/31/20221,807111107179N/A
12/31/20211,40193172224N/A
9/30/20211,810117209254N/A
6/30/20211,752105243281N/A
3/31/20211,688107290324N/A
12/31/20201,728109218252N/A
9/30/20201,834121205236N/A
6/30/20201,904137162198N/A
3/31/20201,98613983122N/A
12/31/20191,946129N/A110N/A
9/30/20191,938130N/A163N/A
6/30/20191,930123N/A152N/A
3/31/20191,928123N/A161N/A
12/31/20181,920104N/A154N/A
9/30/20181,86681N/A63N/A
6/30/20181,80581N/A118N/A
3/31/20181,70066N/A76N/A
12/31/20171,63582N/A105N/A
9/30/20171,55686N/A109N/A
6/30/20171,48580N/A68N/A
3/31/20171,42880N/A91N/A
12/31/20161,35168N/A67N/A
9/30/20161,30066N/A91N/A
6/30/20161,22458N/A73N/A
3/31/20161,14953N/A82N/A
12/31/20151,10756N/A112N/A
9/30/20151,04850N/A76N/A
6/30/20151,01847N/A97N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: JBTMDas prognostizierte Gewinnwachstum (39.1% pro Jahr) liegt über der Sparquote (3.5%).

Ertrag vs. Markt: JBTMDie Erträge des Unternehmens (39.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (16.8% pro Jahr).

Hohe Wachstumserträge: JBTMEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: JBTMDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.7% pro Jahr).

Hohe Wachstumseinnahmen: JBTMDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von JBTM in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/22 17:14
Aktienkurs zum Tagesende2026/05/22 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

JBT Marel Corporation wird von 16 Analysten beobachtet. 6 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Mircea DobreBaird
John JoynerBMO Capital Markets Equity Research
Andrew ObinBofA Global Research